Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index

[1]  G. Serrero,et al.  GP88 (Progranulin) Confers Fulvestrant (Faslodex, ICI 182,780) Resistance to Human Breast Cancer Cells , 2014 .

[2]  G. Serrero,et al.  Abstract P2-10-40: Correlation between expression of the prognostic marker Progranulin (GP88) with Oncotype Dx Recurrence Score in estrogen receptor positive breast tumors , 2012 .

[3]  J. Weaver,et al.  Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma , 2012, Breast Cancer Research.

[4]  G. Serrero,et al.  GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells , 2011, BMC Cancer.

[5]  M. Zhan,et al.  Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects , 2011, Breast cancer : basic and clinical research.

[6]  Yuval Kluger,et al.  Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models , 2010, Breast Cancer Research.

[7]  J. Halper.  Growth Factors as Active Participants in Carcinogenesis: A Perspective , 2009, Veterinary pathology.

[8]  I. Ellis,et al.  The Nottingham Prognostic Index for Invasive Carcinoma of the Breast , 2008, Pathology & Oncology Research.

[9]  F. Ni,et al.  Structure dissection of human progranulin identifies well‐folded granulin/epithelin modules with unique functional activities , 2008, Protein science : a publication of the Protein Society.

[10]  S. Huffel,et al.  Short-Term Prognostic Index for Breast Cancer: NPI or Lpi , 2007, Pathology research international.

[11]  K. Bible,et al.  Prosurvival function of the granulin‐epithelin precursor is important in tumor progression and chemoresponse , 2007, International journal of cancer.

[12]  Mitch Dowsett,et al.  Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. , 2007, Journal of the National Cancer Institute.

[13]  Carlos Caldas,et al.  Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index , 2006, Clinical Cancer Research.

[14]  Mitch Dowsett,et al.  Proliferation marker Ki-67 in early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[16]  G. Serrero,et al.  PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. , 2004, Carcinogenesis.

[17]  J. Hayashi,et al.  PC Cell-Derived Growth Factor Mediates Tamoxifen Resistance and Promotes Tumor Growth of Human Breast Cancer Cells , 2004, Cancer Research.

[18]  G. Serrero,et al.  Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. , 2003, Human pathology.

[19]  C. H. Ong,et al.  Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. , 2003, Histology and histopathology.

[20]  G. Serrero.  Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. , 2003, Biochemical and biophysical research communications.

[21]  Zhiheng He,et al.  Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis , 2003, Journal of Molecular Medicine.

[22]  C. H. Ong,et al.  Progranulin is a mediator of the wound response , 2003, Nature Medicine.

[23]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[24]  H Donis-Keller,et al.  The Cooperative Breast Cancer Tissue Resource: archival tissue for the investigation of tumor markers. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  G. Serrero,et al.  Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Romano,et al.  Biological activities and signaling pathways of the granulin/epithelin precursor. , 1999, Cancer research.

[27]  K. Shimokawa,et al.  Preoperative diagnosis of breast diseases by dynamic MR mammography: Cut-off point establishment for signal intensity ratio , 1998 .

[28]  R. Blamey,et al.  A prognostic index in primary breast cancer. , 1982, British Journal of Cancer.

[29]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[30]  I. Ellis,et al.  The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.

[31]  J. Brown,et al.  Comment on the Nottingham Prognostic Index , 2004, Breast Cancer Research and Treatment.

[32]  C. Axelsson,et al.  The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG) , 2004, Breast Cancer Research and Treatment.

[33]  E. Petricoin,et al.  The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  J. Coindre,et al.  Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. , 1998, European journal of cancer.

[35]  E. P. Lewis.  In perspective. , 1972, Nursing outlook.